Nath Bio-Genes (I) Ltd
NSE:NATHBIOGEN
Nath Bio-Genes (I) Ltd
NSE:NATHBIOGEN
Price:
137.46
INR
6.54%
Market Closed
Market Cap:
₹2.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nath Bio-Genes (I) Ltd
NSE:NATHBIOGEN
|
IN |
|
Fossil Group Inc
NASDAQ:FOSL
|
US |
|
Genie Energy Ltd
NYSE:GNE
|
US |
|
E
|
Eli Lilly and Co
XETRA:LLY
|
US |
|
Tryg A/S
CSE:TRYG
|
DK |
|
B
|
Blue Owl Technology Finance Corp
NYSE:OTF
|
US |
|
J
|
Jiangsu New Energy Development Co Ltd
SSE:603693
|
CN |
|
Harworth Group PLC
LSE:HWG
|
UK |
|
T
|
Tai Cheung Holdings Ltd
HKEX:88
|
HK |
|
Rallis India Ltd
NSE:RALLIS
|
IN |
|
Medica Sur SAB de CV
BMV:MEDICAB
|
MX |
|
Xelpmoc Design and Tech Ltd
NSE:XELPMOC
|
IN |
|
G
|
Great China Metal Ind. Co Ltd
TWSE:9905
|
TW |
|
V
|
Vonovia SE
OTC:VNNVF
|
DE |
|
X
|
XL Holdings Bhd
KLSE:XL
|
MY |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NATHBIOGEN's stock price target?
Not Available
NATHBIOGEN doesn't have any price targets made by Wall Street professionals.
What is Nath Bio-Genes (I) Ltd's Revenue forecast?
Projected CAGR
-4%
-4%
For the last 12 years the
compound annual growth rate for
Nath Bio-Genes (I) Ltd's revenue is
8%.
The projected
CAGR
for the next 4 years is
-4%.
What is Nath Bio-Genes (I) Ltd's Net Income forecast?
Projected CAGR
7%
7%
For the last 12 years the
compound annual growth rate for
Nath Bio-Genes (I) Ltd's net income is
10%.
The projected
CAGR
for the next 4 years is
7%.
